GALIMEDIX THERAPEUTICS, INC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.galimedix.com
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Galimedix Therapeutics Inc
- Target Recruit Count
- 110
- Registration Number
- NCT06659549
- Locations
- 🇺🇸
Speciality Retina Center, Dr. Shailesh Gupta, Deerfield Beach, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath